Chronic Pericarditis

The key functional problem is loss of normal diastolic expansion. Persistent inflammation can thicken the pericardium, create adhesions, or allow fluid to accumulate around the heart. If scarring progresses to constriction, the heart cannot expand adequately during diastole, reducing cardiac filling and potentially impairing overall heart function. These structural effects explain the clinical importance of chronic disease.

Inflammation may leave behind progressive scarring rather than remaining only an active inflammatory process. The resulting constrictive state limits the heart’s expansion during diastole, so impaired filling becomes a central clinical concern. Recognizing this transition matters because evaluation must distinguish ongoing inflammation, fluid accumulation, and structural constriction when assessing effects on heart function.

Cause-directed assessment is important because chronic pericardial inflammation may be associated with infection, autoimmune disease, or previous cardiac injury. Identifying the likely trigger gives clinical management a target beyond controlling inflammation itself. It also helps clinicians consider the risk of persistent disease, recurrent effusion, or progressive constriction and organize an appropriate evaluation strategy.

An effusion represents fluid accumulation around the heart, whereas constriction reflects structural limitation caused by progressive scarring. Both can affect cardiac performance, but they do so through different mechanisms: fluid creates an abnormal pericardial collection, while constriction prevents adequate expansion during diastole. Distinguishing them helps organize imaging findings and assess the nature of functional impairment.

Clinical evaluation combines symptoms and physical findings with electrocardiography, echocardiography, and other imaging. Together, these methods help identify inflammation, pericardial effusion, or constriction and clarify how the pericardium is affecting cardiac function. The same assessment also supports investigation of potential causes, including infection, autoimmune disease, or previous cardiac injury.

Management has three linked aims: control inflammation, treat the underlying cause, and prevent complications. Prevention is particularly important when disease may lead to recurrent pericardial effusion or chronic constriction that limits cardiac expansion. This framework connects therapy with both the active inflammatory process and the structural consequences that can impair filling and overall heart function.